Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8461563 | 0.87 | MAPT (0.35) | ATMLMNACA1CA2MAPT | |
| SCHEMBL9524578 | 0.84 | CES2 (0.41) | CES2CES1ALDH1A1TSHRALOX15 | |
| SCHEMBL9522141 | 0.84 | CES2 (0.41) | CES2CES1ALDH1A1TSHRALOX15 | |
| SCHEMBL23181422 | 0.82 | CES2 (0.39) | CES2CES1ALDH1A1TSHRALOX15 | |
| SCHEMBL10365514 | 0.82 | CES2 (0.39) | CES2CES1ALDH1A1TSHRALOX15 | |
| SCHEMBL9626474 | 0.78 | MAPT (0.52) | ALDH1A1TSHRALOX15CYP3A4MAPK1 | |
| SCHEMBL12981369 | 0.78 | ALDH1A1 (0.44) | CES2CES1ALDH1A1CYP3A4ATM | |
| SCHEMBL2017897 | 0.76 | CES2 (0.42) | CES2CES1ALDH1A1MAOAMAOB | |
| SCHEMBL30510719 | 0.76 | CES2 (0.42) | CES2CES1ALDH1A1TSHRALOX15 | |
| SCHEMBL1965137 | 0.76 | TPMT (0.41) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180133212-A1 | COMBINATION OF A BCL-2 INHIBITOR AND A BROMODOMAIN INHIBITOR FOR TREATING CANCER | GILEAD SCIENCES, INC. | 2018-05-17 | — | — | US | disclosed |
| CN-102652159-B | Stain-resistant aqueous coating composition | AKZO NOBEL COATINGS INT BV | 2014-08-13 | — | — | CN | disclosed |
| EP-2513237-B1 | STAIN-BLOCKING AQUEOUS COATING COMPOSITION | AKZO NOBEL COATINGS INT BV (NL) | 2014-06-18 | — | — | EP | disclosed |
| US-8709609-B2 | Stain-blocking aqueous coating composition | AKZO NOVEL COATINGS INTERNATIONAL B.V. (NL) | 2014-04-29 | — | — | US | disclosed |
| EP-2513237-A1 | STAIN-BLOCKING AQUEOUS COATING COMPOSITION | Akzo Nobel Coatings International B.V. (NL) | 2012-10-24 | — | — | EP | disclosed |
| US-20120244368-A1 | STAIN-BLOCKING AQUEOUS COATING COMPOSITION | AKZO NOBEL COATING INTERNATIONAL B.V. (NL) | 2012-09-27 | — | — | US | disclosed |
| CN-102652159-A | Stain-resistant aqueous coating composition | AKZO NOBEL COATINGS INT BV | 2012-08-29 | — | — | CN | disclosed |
| WO-2011073164-A1 | STAIN-BLOCKING AQUEOUS COATING COMPOSITION | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2011-06-23 | — | — | WO | disclosed |
| EP-0197274-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED STYRENES | BAYER AG (DE) | 1989-01-04 | — | — | EP | disclosed |
| US-4650910-A | CLEAVAGE OF N-ACYL-B-PHENETHYLAMINES WITH BASE | BAYER AKTIENGESELLSCHAFT (DE) | 1987-03-17 | — | — | US | disclosed |
| EP-0197274-A1 | Process for the preparation of substituted styrenes | BAYER AG (DE) | 1986-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180133212-A1 | COMBINATION OF A BCL-2 INHIBITOR AND A BROMODOMAIN INHIBITOR FOR TREATING CANCER | BCL2, BAK1, BRD4 | CES2 3633/4885CES1 3696/4885ALDH1A1 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.